New Release
Shorten database lock by up to 6 weeks with Data Findings
Platform
Use Cases
Success Stories
Pricing
Company
Contact us

Our News

Stay Updated With Rivia

Press Releases
November 5, 2026

Rivia Expands Clinical Trial Intelligence Platform with New AI-Powered Data Findings Module

Rivia

Introducing Data Findings, an AI-powered data review module designed to reduce costly delays in drug development through automated data checks.

Press Releases
March 18, 2026

Rivia Raises $15M Series A to Build the Agentic Data Engine Powering the Future of Global Clinical Trials

Rivia

Rivia’s AI-powered data engine unifies fragmented clinical trial data, applies specific scientific logic at scale, and embeds agents directly into high-volume review workflows for operators to reduce trial costs by up to 50%

Filter by:
All Blogs
Press Releases
Industry
Partner
Customer
Product
Showing X of X Results
Continuous monitoring in clinical trials: how to turn RBQM into a decision advantage
Industry
September 16, 2026

Continuous Monitoring in Clinical Trials: How to Turn RBQM Into a Decision Advantage

See what it takes to turn your RBQM program into a decision advantage under ICH E6(R3): real-time data, documented findings, and separate KRI/QTL calculation.

ICH E6(R3) From Guideline to Practice
Industry
September 3, 2026

Operationalizing ICH E6(R3): Closing the Gap Between Guideline and Practice

Your QMP meets ICH E6(R3). Does your daily oversight? Four practical moves sponsors use to close the gap, from CtQ factors to continuous signal review.

The FDA wants Real-Time clinical trials
Industry
June 5, 2026

The FDA Wants Real-Time Clinical Trials. Your Data Infrastructure Decides If You're Ready.

Real-time regulatory co-review requires more than better AI models. It requires data infrastructure that is continuous, cross-domain, and auditable by design, starting now.

Customer
May 10, 2026

How Omeicos Identified Biomarker Signals and Safety Trends with Rivia

Omeicos Therapeutics used Rivia's platform to manage their Phase 2a clinical trial for OMT-28, a drug for Primary Mitochondrial Disease.

Product
October 16, 2025

RIVIA’s Spark AI Accelerates Clinical Data Review: Accepted for Presentation at ESMO AI 2025

Discover how RIVIA’s Spark AI cut data review time by 91%, empowering clinical teams with real-time insights at ESMO AI 2025.

Product
October 13, 2025

Operationalizing RBQM Through Centralized Data Automation

Discover how RIVIA automates Risk-Based Quality Management (RBQM) through centralized data integration.

Partner
October 10, 2025

RIVIA Expands Scientific Leadership with the Appointment of Tristan Heintz as Scientific Expert

Partner
September 19, 2025

RIVIA Strengthens Advisory Board with Appointment of Dr. Rich Christie to Accelerate Global Expansion in Clinical Trial Technology

Rivia Strengthens Advisory Board with Appointment of Dr. Rich Christie to Accelerate Global Expansion in Clinical Trial Technology

FAQs

News FAQ #1

News FAQ #2

News FAQ #3

News FAQ #4

News FAQ #5

Don't just manage your trials. Master them.

Unlock the power of seamless data integration for faster, smarter decisions.

Book a demoContact us

Rivia steers therapeutic innovators to breakthroughs in clinical trials

Contact us

Rivia

Why Rivia?
Pricing
Success Stories

Use Cases

Medical and Clinical Science
Safety Monitoring
Clinical Operations
Executive Oversight
Data Management

Company

About Us
Trust
News
Careers

Our Office

Bleicherweg 72
8002 Zürich Switzerland
info@rivia.com

© 2026 Rivia . All Rights Reserved

Manage CookiesCookie PolicyTerms of UsePrivacy Policy
Site by New Now
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Preferences
DenyAccept